Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UC-MSC and BMMC in Spinal Cord Injury
NCT02237547Phase 2Withdrawn
- Sponsor
- Translational Biosciences
- Start
- Sep 2014
- Primary completion
- Jan 2019
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of human umbilical cord derived mesenchymal stem cells in spinal cord injury (SCI), sponsored by Translational Biosciences. Planned start Sep 2014; status: withdrawn.
02
Drugs
human umbilical cord derived mesenchymal stem cells
03
Conditions
spinal cord injury (SCI)
Beyond the preview
Go deeper on NCT02237547.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02237547.